IN8bio, Inc.
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologou…
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
IN8bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDIN8bio, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of IN8bio, Inc..
If you want to see a demo, head over to the financial segments of AAPL